What is the dose of intravenous (IV) fluconazole for fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intravenous Fluconazole Dosing for Fungal Infections

For most invasive Candida infections, use IV fluconazole 400 mg (6 mg/kg) daily, with a loading dose of 800 mg (12 mg/kg) on day 1 for severe infections. 1

Dosing by Infection Type

Esophageal Candidiasis

  • Standard dose: 200-400 mg (3-6 mg/kg) IV daily for 14-21 days 1
  • For patients unable to tolerate oral therapy, use 400 mg (6 mg/kg) IV daily 1
  • Alternative: Echinocandin (micafungin 150 mg daily, caspofungin 70 mg loading then 50 mg daily, or anidulafungin 200 mg daily) 1

Oropharyngeal Candidiasis (Moderate to Severe)

  • Oral preferred: 100-200 mg daily for 7-14 days 1
  • IV alternative for refractory disease: Amphotericin B deoxycholate 0.3 mg/kg daily 1

Candidemia and Invasive Candidiasis

  • Systemic infections: 200-400 mg IV daily, though optimal dosing not fully established 2
  • Duration: Continue until clinical parameters and laboratory tests indicate resolution of active infection 2
  • Important: Inadequate treatment duration leads to recurrence 2

CNS Candidiasis

  • Dose: 400-800 mg (6-12 mg/kg) IV daily for patients unable to tolerate amphotericin B 1
  • Continue until all signs, symptoms, CSF abnormalities, and radiologic findings resolve 1
  • Remove intraventricular devices if present 1

Urinary Tract Infections

  • Symptomatic cystitis: 200 mg (3 mg/kg) daily for 14 days 1
  • Pyelonephritis: 200-400 mg (3-6 mg/kg) daily for 14 days 1
  • Treat as candidemia if disseminated candidiasis suspected 1

Cryptococcal Meningitis

  • Acute treatment: 400 mg IV on day 1, then 200 mg daily 2
  • May increase to 400 mg daily based on response 2
  • Duration: 10-12 weeks after CSF becomes culture-negative 2
  • Consolidation: 400-600 mg daily for 8 weeks 1
  • Maintenance (AIDS patients): 200 mg daily for 6-12 months 1, 2

Non-Meningeal Cryptococcosis

  • Severe disease: Treat as CNS disease for 12 months 1
  • Mild-to-moderate: 400 mg daily for 6-12 months 1

Chronic Disseminated Candidiasis

  • Continue treatment until lesions resolve (typically 3-6 months) 1
  • Fluconazole can be used as step-down therapy in stable patients 1

Key Dosing Principles

Loading Dose Strategy

  • General principle: Use a loading dose of twice the daily dose on day 1 to achieve near-steady-state concentrations by day 2 2
  • This applies to all serious infections requiring rapid therapeutic levels 2

Route Equivalence

  • IV and oral doses are identical due to rapid and nearly complete oral absorption 2
  • Switch to oral when patient can tolerate and clinical stability achieved 1

Special Populations

  • Neonates: 12 mg/kg/day for candidiasis 1
  • Bone marrow transplant prophylaxis: 400 mg daily, starting several days before anticipated neutropenia, continuing 7 days after neutrophil count >1000 cells/mm³ 2

Common Pitfalls

  • Underdosing severe infections: Many clinicians use 200 mg when 400 mg is indicated for invasive disease 1
  • Inadequate duration: Stopping too early leads to relapse; continue until clinical and laboratory resolution 2
  • Not adjusting for renal function: Fluconazole requires dose reduction in renal impairment 2
  • Species-specific resistance: C. krusei is intrinsically resistant; C. glabrata often has reduced susceptibility—consider echinocandin instead 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.